HWM
JAZZ icon

HB Wealth Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

HB Wealth Management’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$550K Buy
2,910
+626
+27% +$109K ﹤0.01% 928
2025
Q4 		$388K Buy
2,284
+226
+11% +$34.6K ﹤0.01% 1011
2025
Q3 		$271K Buy
+2,058
New +$247K ﹤0.01% 1126

Other funds holding JAZZ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

HB Wealth Management's JAZZ Position: Q1 2026 in Review

HB Wealth Management increased its Jazz Pharmaceuticals (JAZZ) stake by 27% in Q1 2026, buying an estimated $109K and bringing the position to 2,910 shares worth $550K. The position accounts for ﹤0.01% of the portfolio, ranked #928.

HB Wealth Management first reported a position in JAZZ in Q3 2025 and has held it in 3 quarters since. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

  • HB Wealth Management held 2,910 shares of Jazz Pharmaceuticals worth $550K as of Q1 2026.
  • HB Wealth Management bought 626 Jazz Pharmaceuticals shares in Q1 2026, an estimated $109K.
  • Jazz Pharmaceuticals made up ﹤0.01% of HB Wealth Management's portfolio in Q1 2026, its #928 holding.
  • HB Wealth Management first reported a position in Jazz Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on HB Wealth Management's 13F filing for Q1 2026, filed 27 Apr 2026.